Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of the Efficacy and Safety of Topical Hydrocortisone Treatment on Clinical Signs and Symptoms of Dry Eye Disease Associated With Moderate Meibomian Gland Dysfunction

NCT05159284 is registered in ClinicalTrials.gov with Laboratorios Thea, Spain as lead sponsor.

NCT NCT05159284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05159284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of the Efficacy and Safety of Topical Hydrocortisone Treatment on Clinical Signs and Symptoms of Dry Eye Disease Associated With Moderate Meibomian Gland Dysfunction
Lead sponsor
Laboratorios Thea, Spain
Phase
Phase 4
Overall status
Unknown status
Start date
November 9, 2021
Completion date
March 31, 2025
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, meibomian gland dysfunction